Cow's milk and rice fermented with Lactobacillus paracasei CBA L74 prevent infectious diseases in children: A randomized controlled trial

Clinical Nutrition

Volumn 36, Issue 1, 2017, Pages 118-125

  Nocerino, Rita ^a   Paparo, Lorella ^a   Terrin, Gianluca ^b   Pezzella, Vincenza ^a   Amoroso, Antonio ^a   Cosenza, Linda ^a   Cecere, Gaetano ^a   De Marco, Giulio ^a   Micillo, Maria ^a   Albano, Fabio ^a   Nugnes, Rosa ^a   Ferri, Pasqualina ^a   Ciccarelli, Giuseppe ^a   Giaccio, Giuliana ^a   Spadaro, Raffaella ^a   Maddalena, Ylenia ^a   Berni Canani, Francesco ^c   Berni Canani, Roberto ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Acquired immunity; Acute gastroenteritis; Innate immunity; Probiotics; Upper respiratory tract infections

Indexed keywords

ALPHA DEFENSIN; BETA DEFENSIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; SECRETORY IMMUNOGLOBULIN; ANTIMICROBIAL CATIONIC PEPTIDE; BIOLOGICAL MARKER; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN;

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CONTROLLED STUDY; DAY CARE; DOUBLE BLIND PROCEDURE; FEMALE; FERMENTED MILK PRODUCT; FERMENTED PRODUCT; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; INNATE IMMUNITY; LACTOBACILLUS PARACASEI; MALE; NONHUMAN; NORMAL HUMAN; PEDIATRICIAN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RICE; SEASONAL VARIATION; UPPER RESPIRATORY TRACT INFECTION; ACUTE DISEASE; ANIMAL; BOVINE; CHEMISTRY; COMMUNICABLE DISEASE; DIET; FECES; FERMENTATION; GASTROENTERITIS; INFANT; METABOLISM; MICROBIOLOGY; MILK; ORYZA; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ALPHA-DEFENSINS; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; BIOMARKERS; CATTLE; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; DIET; DOUBLE-BLIND METHOD; FECES; FEMALE; FERMENTATION; GASTROENTERITIS; HUMANS; INFANT; LACTOBACILLUS PARACASEI; MALE; MILK; ORYZA; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS;

EID: 84951796575     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.12.004     Document Type: Article

References (30)

1. Hatakka, K., Savilahti, E., Pönkä, A., Meurman, J.H., Poussa, T., Näse, L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ, 322(7298), 2001, 1327.
2. Silverstein, M., Sales, A.E., Koepsell, T.D., Health care utilization and expenditures associated with child care attendance: a nationally representative sample. Pediatrics 111:4 Pt 1 (2003), e371–5.
3. Haskins, R., Acute illness in day care: how much does it cost?. Bull N. Y Acad Med 65 (1989), 319–343.
4. Granier, A., Goulet, O., Hoarau, C., Fermentation products: immunological effects on human and animal models. Pediatr Res 74:2 (2013), 238–244, 10.1038/pr.2013.76.
5. Guarino, A., Ashkenazi, S., Gendrel, D., Lo Vecchio, A., Shamir, R., Szajewska, H., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for pediatric infectious diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr 59:1 (2014), 132–152, 10.1097/MPG.0000000000000375.
6. Agustina, R., Kok, F.J., van de Rest, O., Fahmida, U., Firmansyah, A., Lukito, W., et al. Randomized trial of probiotics and calcium on diarrhea and respiratory tract infections in Indonesian children. Pediatrics 129:5 (2012), e1155–64, 10.1542/peds.2011-1379.
7. Maldonado, J., Cañabate, F., Sempere, L., Vela, F., Sánchez, A.R., Narbona, E., et al. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr 54:1 (2012), 55–61, 10.1097/MPG.0b013e3182333f18.
8. Hojsak, I., Abdović, S., Szajewska, H., Milosević, M., Krznarić, Z., Kolacek, S., Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics 125:5 (2010), e1171–7, 10.1542/peds.2009-2568.
9. Raqib, R., Sarker, P., Mily, A., Alam, N.H., Arifuzzaman, A.S., Rekha, R.S., et al. Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial. BMC Infect Dis, 12, 2012, 111.
10. Pregliasco, F., Anselmi, G., Fonte, L., Giussani, F., Schieppati, S., Soletti, L., A new chance of preventing winter diseases by the administration of synbiotic formulations. J Clin Gastroenterol 42:Suppl 3 Pt 2 (2008), S224–S233, 10.1097/MCG.0b013e31817e1c91.
11. Cazzola, M., Pham-Thi, N., Kerihuel, J.C., Durand, H., Bohbot, S., Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv Respir Dis 4:5 (2010), 271–278, 10.1177/1753465810379010.
12. Hojsak, I., Močić Pavić, A., Kos, T., Dumančić, J., Kolaček, S., Bifidobacterium animalis subsp. lactis in prevention of common infections in healthy children attending day care centers – randomized, double blind, placebo-controlled study. Clin Nutr 35 (2016), 587–591, 10.1016/j.clnu.2015.05.004.
13. Zagato, E., Mileti, E., Massimiliano, L., Fasano, F., Budelli, A., Penna, G., et al. Lactobacillus paracasei CBA L74 metabolic products and fermented milk for infant formula have anti-inflammatory activity on dendritic cells in vitro and protective effects against colitis and an enteric pathogen in vivo. PLoS One, 9(2), 2014, e87615, 10.1371/journal.pone.0087615.
14. Wang, G., Mishra, B., Lau, K., Lushnikova, T., Golla, R., Wang, X., Antimicrobial peptides in 2014. Pharm (Basel) 8:1 (2015), 123–150, 10.3390/ph8010123.
15. Habil, N., Abate, W., Beal, J., Foey, A.D., Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human β-defensin-2: dependence on inflammatory cytokines. Benef Microbes 5:4 (2014), 483–495, 10.3920/BM2013.0061.
16. Campeotto, F., Suau, A., Kapel, N., Magne, F., Viallon, V., Ferraris, L., et al. A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br J Nutr 105:12 (2011), 1843–1851, 10.1017/S0007114510005702.
17. Schlee, M., Harder, J., Köten, B., Stange, E.F., Wehkamp, J., Fellermann, K., Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 151:3 (2008), 528–535, 10.1111/j.1365-2249.2007.03587.x.
18. Kato, L.M., Kawamoto, S., Maruya, M., Fagarasan, S., Gut TFH and IgA: key players for regulation of bacterial communities and immune homeostasis. Immunol Cell Biol 92:1 (2014), 49–56, 10.1038/icb.2013.54.
19. Veiga, P., Pons, N., Agrawal, A., Oozeer, R., Guyonnet, D., Brazeilles, R., et al. Changes of the human gut microbiome induced by a fermented milk product. Sci Rep, 4, 2014, 6328, 10.1038/srep06328.
20. Baud, O., Giron, S., Aumeran, C., Mouly, D., Bardon, G., Besson, M., et al. First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures. Eur J Clin Microbiol Infect Dis 33:10 (2014), 1757–1762, 10.1007/s10096-014-2127-6.
21. Merenstein, D., Murphy, M., Fokar, A., Hernandez, R.K., Park, H., Nsouli, H., et al. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr 64:7 (2010), 669–677, 10.1038/ejcn.2010.65.
22. Guillemard, E., Tondu, F., Lacoin, F., Schrezenmeir, J., Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103:1 (2010), 58–68, 10.1017/S0007114509991395.
23. Fujita, R., Iimuro, S., Shinozaki, T., Sakamaki, K., Uemura, Y., Takeuchi, A., et al. Decreased duration of acute upper respiratory tract infections with daily intake of fermented milk: a multicenter, double-blinded, randomized comparative study in users of day care facilities for the elderly population. Am J Infect Control 41:12 (2013), 1231–1235, 10.1016/j.ajic.2013.04.005.
24. Vinderola, G., Matar, C., Palacios, J., Perdigón, G., Mucosal immunomodulation by the non-bacterial fraction of milk fermented by Lactobacillus helveticus R389. Int J Food Microbiol 115:2 (2007), 180–186.
25. Matar, C., Valdez, J.C., Medina, M., Rachid, M., Perdigon, G., Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 68:4 (2001), 601–609.
26. Burgain, J., Scher, J., Francius, G., Borges, F., Corgneau, M., Revol-Junelles, A.M., et al. Lactic acid bacteria in dairy food: surface characterization and interactions with food matrix components. Adv Colloid Interface Sci 213 (2014), 21–35, 10.1016/j.cis.2014.09.005.
27. Yao, M., Xu, Q., Luo, Y., Shi, J., Li, Z., Study on reducing antigenic response and IgE-binding inhibitions of four milk proteins of Lactobacillus casei 1134. J Sci Food Agric 95:6 (2015), 1303–1312, 10.1002/jsfa.6823.
28. Ehn, B.M., Allmere, T., Telemo, E., Bengtsson, U., Ekstrand, B., Modification of IgE binding to beta-lactoglobulin by fermentation and proteolysis of cow's milk. J Agric Food Chem 53:9 (2005), 3743–3748.
29. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotics. Nat Rev Gastro Hepat 11:8 (2014), 506–514.
30. Enserink, R., Lugnér, A., Suijkerbuijk, A., Bruijning-Verhagen, P., Smit, H.A., van Pelt, W., Gastrointestinal and respiratory illness in children that do and do not attend child day care centers: a cost-of-illness study. PLoS One, 9(8), 2014, e104940, 10.1371/journal.pone.0104940.